New drug cocktail shows promise for aggressive breast cancer
Disease control
Ongoing
This study tests a combination of two drugs, ribociclib and bicalutamide, in people with advanced triple-negative breast cancer that has a specific marker (androgen receptor). The goal is to see if this combo can shrink tumors or stop them from growing. About 37 participants will…
Phase: PHASE1, PHASE2 • Sponsor: Kari Wisinski • Aim: Disease control
Last updated May 22, 2026 13:55 UTC